Conduit Pharmaceuticals Inc. filed its Annual on Jul 11, 2023 for the period ending Dec 31, 2022. In this report its auditor, Marcum LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.86 USD | -3.38% | -5.61% | -37.14% |
May. 14 | Conduit Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 19 | Conduit Pharmaceuticals Inc. Appoints Joanne Holland as Chief Scientific Officer | CI |
1st Jan change | Capi. | |
---|---|---|
-37.14% | 211M | |
+55.70% | 59.34B | |
+41.08% | 40.24B | |
-5.39% | 39.88B | |
-5.56% | 28.55B | |
+16.46% | 27.26B | |
-20.56% | 19.23B | |
+33.03% | 12.61B | |
+25.85% | 12.28B | |
+2.72% | 12.49B |
- Stock Market
- Equities
- CDT Stock
- News Conduit Pharmaceuticals Inc.
- Conduit Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt